Biotechnology Fund Class Fund Current Liabilities
| RYBOX Fund | USD 65.44 0.12 0.18% |
Biotechnology Fund Class fundamentals help investors to digest information that contributes to Biotechnology Fund's financial success or failures. It also enables traders to predict the movement of Biotechnology Mutual Fund. The fundamental analysis module provides a way to measure Biotechnology Fund's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotechnology Fund mutual fund.
Biotechnology |
Biotechnology Fund Class Mutual Fund Current Liabilities Analysis
Biotechnology Fund's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Biotechnology Fund Class has a Current Liabilities of 0.0. This indicator is about the same for the Rydex Funds average (which is currently at 0.0) family and about the same as Health (which currently averages 0.0) category. This indicator is about the same for all United States funds average (which is currently at 0.0).
Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
| All Next | Launch Module |
Fund Asset Allocation for Biotechnology Fund
The fund consists of 98.56% investments in stocks, with the rest of investments allocated between different money market instruments.Asset allocation divides Biotechnology Fund's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Biotechnology Fundamentals
| Price To Earning | 18.21 X | ||||
| Price To Book | 3.49 X | ||||
| Price To Sales | 4.68 X | ||||
| Total Asset | 15.63 M | ||||
| Year To Date Return | 1.09 % | ||||
| One Year Return | 8.14 % | ||||
| Three Year Return | (4.09) % | ||||
| Five Year Return | 5.74 % | ||||
| Ten Year Return | 17.31 % | ||||
| Net Asset | 117.21 M | ||||
| Minimum Initial Investment | 2.5 K | ||||
| Cash Position Weight | 1.44 % | ||||
| Equity Positions Weight | 98.56 % |
About Biotechnology Fund Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotechnology Fund Class's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotechnology Fund using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotechnology Fund Class based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| WMT | Walmart | |
| MIDNX | Matthews India Fund | |
| QCOM | Qualcomm Incorporated |
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |